--- title: India Partially Lifts Export Hydroxychloroquine Ban description: India partially lifted a ban on the exports of a malaria drug after President Donald Trump sought supplies for the U.S. canonical: https://time.com/5816617/india-lifts-hydroxychloroquine-export-ban/ author: TIME article:opinion: false article:content_tier: free article:published_time: 2020-04-07T08:03:54.000Z article:modified_time: 2026-08-04T07:52:13.060Z article:section: Health og:title: India Partially Lifts Export Ban on Potential Coronavirus Treatment After Trump Call og:description: Normally used to treat malaria, hydroxychloroquine yielded promising yet inconclusive results in a small coronavirus trial og:url: https://time.com/5816617/india-lifts-hydroxychloroquine-export-ban/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt7c46b27db31ac022/698a0c8086f68e7b506ee918/hydroxychloroquine-india.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 og:image:width: 1024 og:image:height: 576 og:image:alt: Hydroxychloroquine Sulfate Medication Illustration og:type: article twitter:card: summary_large_image twitter:title: India Partially Lifts Export Ban on Potential Coronavirus Treatment After Trump Call twitter:description: Normally used to treat malaria, hydroxychloroquine yielded promising yet inconclusive results in a small coronavirus trial twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt7c46b27db31ac022/698a0c8086f68e7b506ee918/hydroxychloroquine-india.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 ---  # India Partially Lifts Export Ban on Potential Coronavirus Treatment After Trump Call > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: September 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=038954db-ac19-4a39-a37b-a28298364e73&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Weekdays | | Worth Your Time | A weekly guide to what to watch, read, and more | Weekly | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=038954db-ac19-4a39-a37b-a28298364e73&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=038954db-ac19-4a39-a37b-a28298364e73&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ### Sources * TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=038954db-ac19-4a39-a37b-a28298364e73&cr=time-nl-network-2026q3-v1) ## Video: President Trump Says U.S. Bought 'A Tremendous Amount' of Hydroxychloroquine [Watch (HLS stream): President Trump Says U.S. Bought 'A Tremendous Amount' of Hydroxychloroquine](https://cdn.jwplayer.com/manifests/axBMhSwP.m3u8) (0:46)  _Published 2020-04-06. Trump said that the U.S. has secured 29 million choloroquine or hydroxychloroquine pills for its medical stockpile and American drugmakers._ by [Archana Chaudhary / Bloomberg](https://time.com/author/bloomberg/) ## Archana Chaudhary / Bloomberg Contributor Apr 7, 2020 8:03 AM UTC  In this photo illustration a pack of Hydroxychloroquine Sulfate medication is displayed on March 26, 2020 in London, United Kingdom. In this photo illustration a pack of Hydroxychloroquine Sulfate medication is displayed on March 26, 2020 in London, United Kingdom. John Phillips–Getty Images by [Archana Chaudhary / Bloomberg](https://time.com/author/bloomberg/) ## Archana Chaudhary / Bloomberg Contributor Apr 7, 2020 8:03 AM UTC India partially lifted a ban on the exports of a malaria drug after President Donald Trump sought supplies for the U.S., according to government officials with knowledge of the matter. Exports of hydroxychloroquine and paracetamol will be allowed depending on availability of stock after meeting domestic requirements and existing orders, said the government officials, who asked not to be identified citing rules. Shipments will be restricted and permission will be on humanitarian ground, they added. The spokesman for the trade ministry was not immediately available for comment. Normally used to treat malaria, hydroxychloroquine yielded promising yet [inconclusive results](https://www.bloomberg.com/news/articles/2020-03-30/u-s-allows-emergency-use-of-drug-trump-backed-to-treat-virus) in a small coronavirus trial. While Trump has said the drug is safe, it carries significant side effects. China, Europe and South Korea recommend it as one of several treatments for Covid-19 patients, while India itself advocates health-care workers take the drug regularly as a [preventive measure](https://www.bloomberg.com/news/articles/2020-03-25/india-bans-exports-of-trump-backed-virus-drug-as-demand-surges). Still, some top scientists, including White House coronavirus task force member Anthony Fauci, have called reports that the drug might work anecdotal, and said there needs to be further study before its use is encouraged. Trump said at the White House on Monday he was unaware Indian Prime Minister Narendra Modi had banned the export of the drug, and noted he asked Modi to ensure supply of the medicine. If New Delhi declined to ship the medicine, the president [said](https://www.bloomberg.com/news/articles/2020-04-06/trump-says-he-hopes-india-allows-malaria-drug-exports-to-u-s) there may be retaliation. India’s export ban had cut off [half of U.S.’ supplies](https://www.bloomberg.com/news/articles/2020-04-06/half-the-u-s-supply-of-trump-touted-virus-drug-now-cut-off) of the drugs. According to data compiled by Bloomberg Intelligence, 47% of the U.S. supply of the drug last year came from India makers. Only a handful of suppliers in the top 10 are non-Indian, such as Actavis, now a subsidiary of Israeli generics giant Teva Pharmaceutical Industries Ltd. India’s Department of Pharmaceuticals and Ministry of External Affairs will decide on overseas allocations of the drug, an official said. India’s trade regulator, the Directorate General of Foreign Trade had on March 25 restricted the exports of hydroxychloroquine. ### ‘Personal Rapport’ The trade regulator also [allowed](https://dgft.gov.in/sites/default/files/Noti%202%20Final%5F0.pdf) exports of over two dozen drug formulation and active pharmaceutical ingredients — the chemicals that make a finished drug work — in a notification issued on April 6\. These were earlier put in the restricted list. India’s decision to lift the ban was driven both by its bilateral trade relationship with the U.S. and the personal rapport between Trump and Modi, said Bipul Chatterjee, who heads the CUTS Centre for International Trade, Economics and Environment in Jaipur. “This decision was an ideal example of how trade equations will develop in the post-Covid-19 world, where food and medicines will increasingly become part of national security concerns,” Chatterjee said Tuesday. “In this case, India seems to have enough hydroxychloroquine to export on humanitarian grounds. But we may not see such generosity among nations for many drugs and food items going ahead.” India produces huge quantities of both the drugs, according to one of the government officials. There are also U.S. companies that produce these drugs in India. India is expecting a doubling of the domestic demand for the drugs, the official said, without giving details of current production numbers. He said the government has been assessing the quantities that can be exported while ensuring internal demand is met. Demand for paracetamol and hydroxychloroquine will be continuously monitored, India’s foreign ministry spokesman Anurag Srivastava said. “In view of the humanitarian aspects of the pandemic, it has been decided that India would license paracetamol and HCQ in appropriate quantities to all our neighboring countries who are dependent on our capabilities. We will also be supplying these essential drugs to some nations who have been particularly badly affected by the pandemic.” Earlier, The Hindu newspaper [reported](https://www.thehindu.com/news/international/coronavirus-brazil-seeks-lifting-of-curbs-imposed-by-india-on-export-of-hydroxychloroquine/article31274106.ece) the two-day old ban was revoked after requests from the U.S. and Brazil seeking supplies of the drug. ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/5816617/india-lifts-hydroxychloroquine-export-ban/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/5816617/india-lifts-hydroxychloroquine-export-ban/"},"headline":"India Partially Lifts Export Ban on Potential Coronavirus Treatment After Trump Call","datePublished":"2020-04-07T08:03:54.000Z","dateModified":"2026-08-04T07:52:13.060Z","description":"Normally used to treat malaria, hydroxychloroquine yielded promising yet inconclusive results in a small coronavirus trial","url":"https://time.com/5816617/india-lifts-hydroxychloroquine-export-ban/","keywords":["wire","overnight","COVID-19"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt7c46b27db31ac022/698a0c8086f68e7b506ee918/hydroxychloroquine-india.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Archana Chaudhary / Bloomberg"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt7c46b27db31ac022/698a0c8086f68e7b506ee918/hydroxychloroquine-india.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"Hydroxychloroquine Sulfate Medication Illustration","caption":"Hydroxychloroquine Sulfate Medication Illustration","creditText":"John Phillips–Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://time.com/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"https://time.com/5816617/india-lifts-hydroxychloroquine-export-ban/","name":"India Partially Lifts Export Ban on Potential Coronavirus Treatment After Trump Call"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"President Trump Says U.S. Bought 'A Tremendous Amount' of Hydroxychloroquine","description":"Trump said that the U.S. has secured 29 million choloroquine or hydroxychloroquine pills for its medical stockpile and American drugmakers.","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/axBMhSwP/poster.jpg?width=720","uploadDate":"2020-04-06T12:32:24.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/axBMhSwP.m3u8","embedUrl":"https://time.com/5816617/india-lifts-hydroxychloroquine-export-ban/","duration":"PT46S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/5816617/india-lifts-hydroxychloroquine-export-ban/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```